DCM
AUPH icon

DG Capital Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

DG Capital Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-402,200
Closed -$8.9M – 142
2021
Q3 		$8.9M Sell
402,200
-238,954
-37% -$3.79M 1.81% 18
2021
Q2 		$8.31M Buy
641,154
+50,000
+8% +$637K 1.79% 19
2021
Q1 		$7.68M Buy
+591,154
New +$8.58M 1.83% 20

Other funds holding AUPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

DG Capital Management's AUPH Position: Q4 2021 in Review

DG Capital Management sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2021, closing a stake of 402,200 shares — an estimated $8.9M sold.

DG Capital Management first reported a position in AUPH in Q1 2021 and held it in 3 quarters. The position peaked at $8.9M in Q3 2021. 190 funds tracked by Wall St. Rank hold AUPH as of Q4 2021.

  • DG Capital Management reported no remaining Aurinia Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • DG Capital Management sold 402,200 Aurinia Pharmaceuticals shares in Q4 2021, an estimated $8.9M.
  • DG Capital Management first reported a position in Aurinia Pharmaceuticals in Q1 2021 and held it in 3 quarters.
  • DG Capital Management's Aurinia Pharmaceuticals position peaked at $8.9M in Q3 2021.
  • 190 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2021.

Based on DG Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.